BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28028400)

  • 1. Transcatheter Closure of Patent Foramen Ovale: A Single Center Experience.
    Milev I; Zafirovska P; Zimbakov Z; Idrizi S; Ampova-Sokolov V; Gorgieva E; Ilievska L; Tosheski G; Hristov N; Georgievska-Ismail L; Anguseva T; Mitrev Z
    Open Access Maced J Med Sci; 2016 Dec; 4(4):613-618. PubMed ID: 28028400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure.
    Yoon JH; Kim JS; Lee DH; Shim EJ; Lee SY; Min KS; Cho DJ; Lee HR
    Korean Circ J; 2011 Jul; 41(7):356-62. PubMed ID: 21860636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of percutaneous patent foramen ovale closure on migraine headaches in patients with history of ischemic neurological events.
    Przemysław W; Spisak-Borowska K; Bochenek T; Konarska-Kuszewska E; Machowski J; Trusz-Gluza M; Bajor G; Mizia-Stec K; Giblett JP; Calvert PA
    Postepy Kardiol Interwencyjnej; 2020 Sep; 16(3):315-320. PubMed ID: 33597997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up after percutaneous closure of patent foramen ovale with Amplatzer PFO Occluder: a single center experience.
    Araszkiewicz A; Grygier M; Iwańczyk S; Trojnarska O; Lesiak M; Grajek S
    Postepy Kardiol Interwencyjnej; 2016; 12(1):49-54. PubMed ID: 26966449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
    Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
    Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
    Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes and Quality of Life after Patent Foramen Ovale (PFO) Closure in Patients with Stroke/Transient Ischemic Attack of Undetermined Cause and Other PFO-Associated Clinical Conditions: A Single-Center Experience.
    Evola S; Camarda EA; Triolo OF; Adorno D; D'Agostino A; Novo G; Onorato EM
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism.
    Kumor M; Biernacka EK; Demkow M; Konka M; Płatek AE; Jagodzińska M; Hoffman P
    Postepy Kardiol Interwencyjnej; 2014; 10(3):155-60. PubMed ID: 25489300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.
    Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Asmarats L; Côté M; Rodés-Cabau J
    J Am Coll Cardiol; 2019 Jan; 73(3):278-287. PubMed ID: 30678757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
    Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migraine headache relief after transcatheter closure of patent foramen ovale.
    Reisman M; Christofferson RD; Jesurum J; Olsen JV; Spencer MP; Krabill KA; Diehl L; Aurora S; Gray WA
    J Am Coll Cardiol; 2005 Feb; 45(4):493-5. PubMed ID: 15708692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
    Sitwala P; Khalid MF; Khattak F; Bagai J; Bhogal S; Ladia V; Mukherjee D; Daggubati R; Paul TK
    Cardiovasc Revasc Med; 2019 Aug; 20(8):687-694. PubMed ID: 30282597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and echocardiographic outcomes after percutaneous closure of patent foramen ovale: a single center experience.
    Lanzone AM; Albiero R; Boldi E; Safari D; Serafin P; Lussardi G; Rigamonti ER; Anselmi A
    Minerva Cardiol Angiol; 2023 Apr; 71(2):157-164. PubMed ID: 33703865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter Patent Foramen Ovale Closure Is Effective in Alleviating Migraine in a 5-Year Follow-Up.
    He YD; Yan XL; Qin C; Zhang P; Guo ZN; Yang Y
    Front Neurol; 2019; 10():1224. PubMed ID: 31803135
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.
    Merkler AE; Gialdini G; Yaghi S; Okin PM; Iadecola C; Navi BB; Kamel H
    Stroke; 2017 Nov; 48(11):3073-3077. PubMed ID: 28939677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous closure of patent foramen ovale: a wise approach].
    Gaspardone A; Iani C; Papa M
    G Ital Cardiol (Rome); 2008 Sep; 9(9):593-602. PubMed ID: 18783080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS
    Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.